Task: Please answer the following question about the molecule with SMILES OC(COC1CN2CCC1CC2)(c1ccccc1)C1CCCC1.
Request: Please describe this drug.
Completion: Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
OC(COC1CN2CCC1CC2)(c1ccccc1)C1CCCC1
C1CCC(C1)C(COC2CN3CCC2CC3)(C4=CC=CC=C4)O
2-(1-azabicyclo[2.2.2]octan-3-yloxy)-1-cyclopentyl-1-phenylethanol
Please describe this drug.
Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).